26 Sept 2018
Guangdong Scraps Approvals for Cross-Location Drug Advertising and Radiopharmaceutical Use
The Food and Drug Administration of Guangdong Province will no longer be accepting applications relating to either the cross-location filing of drug advertisements or licences for the use of radiopharmaceuticals (categories I and II) within medical institutions. This procedural change specifically relates to any entity operating within the Guangdong Pilot Free Trade Zone.
For further details (in Chinese), please visit the following link: